[Huagung] February 2026 Revenue NT$111 Million (YoY -28.9%)
Huagung (stock code: 4737) announced its revenue report for February 2026. The revenue for the month was NT$111 million, a decrease of 28.9% compared to the same period last year. The company belongs to the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 4737
Company Name: Huagung
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month's Revenue: NT$110,554 thousand (NT$111 million)
Year-on-year change for the same month: -28.9%
Company Name: Huagung
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month's Revenue: NT$110,554 thousand (NT$111 million)
Year-on-year change for the same month: -28.9%
FAQ
What was Huagung's revenue for February 2026?
Huagung's revenue for February 2026 was NT$110,554 thousand, which is approximately NT$111 million.
How did Huagung's revenue in February 2026 compare to the previous year?
Huagung's revenue in February 2026 experienced a year-on-year decrease of 28.9% compared to the same month in the prior year.
What is the company code for Huagung?
The company code for Huagung is 4737.
In which industry sector does Huagung operate?
Huagung operates within the Biotechnology and Medical industry sector.
What was the specific revenue figure for Huagung in February 2026, expressed in thousands?
The specific revenue figure for Huagung in February 2026, expressed in thousands of New Taiwan Dollars, was NT$110,554 thousand.